Lyribea Capsule 75 mg (Pregabalin)

Adult dose

This medication is administered orally, divided into two doses per day, regardless of meals. 1. Neuropathic pain 1) Peripheral neuropathic pain: Starting dose is 150 mg per day, which can be increased to 300 mg per day after 3 to 7 days. If necessary, the dose can be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain: Starting dose is 150 mg per day, which can be increased to 300 mg after one week.

Child dose

Use in patients under 12 years of age and adolescents aged 12 to 17 is not recommended due to insufficient safety and efficacy data.

This medication may increase the risk of suicidal thoughts or behaviors; therefore, it is essential to consult a physician immediately if there is any change in mood or behavior during treatment. Patients with hypersensitivity to this medication or those with specific genetic lactose metabolism disorders should not take it. Patients with diabetes should be cautious as weight gain may require adjustment of blood sugar control medications. If swelling occurs around the face or neck while taking this medication, it should be stopped immediately and medical personnel must be informed. Elderly patients may experience dizziness or drowsiness after taking this medication, so extra caution is particularly necessary at the start of treatment due to a possible risk of falls. Temporary blurring of vision or changes in vision may occur; if such symptoms arise, a consultation with a physician is necessary. Discontinuing this medication abruptly may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it should be reduced gradually according to a physician's instructions. Patients with a history of substance abuse may be at a higher risk of misuse with this medication and should exercise caution while taking it. Patients with heart or kidney dysfunction should be cautious when taking this medication and may need dose adjustment. Co-administration of this medication with opioid analgesics may increase central nervous system depressant effects, leading to risks such as respiratory distress; caution is advised if taking them together. During early pregnancy, there is a risk of congenital malformations to the fetus; therefore, women who are pregnant or planning to become pregnant should consult with a physician and use effective contraception. Women who are breastfeeding should discuss whether to continue this medication with their physician as it may pass into breast milk and affect the baby. This medication may cause dizziness and drowsiness, so it is advisable to avoid driving or operating hazardous machinery after taking it. Rarely, serious skin reactions may occur; if symptoms such as rash, blisters, or redness appear on the skin, the medication should be discontinued immediately and medical personnel should be informed. In case of overdose, symptoms such as drowsiness, confusion, depression, and seizures may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, difficulty breathing (dyspnea), asthma attacks, breathing abnormalities with cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urinary issues

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoric mood
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is important to maintain storage temperatures between 15 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and safety.

Appearance

Brown hard capsule with a white or pale yellow powder inside

Package unit

30 capsules/bottle, 100 capsules/bottle